# Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.

> **NCT01983657** · PHASE2 · UNKNOWN · sponsor: **Shanghai Pulmonary Hospital, Shanghai, China** · enrollment: 40 (estimated)

## Conditions studied

- Pulmonary Alveolar Proteinosis

## Interventions

- **DRUG:** rhGM-CSF
- **PROCEDURE:** Whole Lung Lavage(WLL)

## Key facts

- **NCT ID:** NCT01983657
- **Lead sponsor:** Shanghai Pulmonary Hospital, Shanghai, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2014-06
- **Final completion:** 2014-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01983657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01983657, "Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01983657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*